Showing results (1-10 of 127) with videos related to
Sort By:
Pageof 13
American Journal of Hematology|April 1, 1989
Cyclosporin A in the treatment of severe aplastic anemia: description of a case complicated by the development of tubercular pericarditis during treatmentE M Pogliani, M Cortellaro, P Foa, et al.Leukemia & Lymphoma|November 1, 1995
Idarubicin in combination with cytarabine and VP-16 in the treatment of post myelodysplastic syndrome acute myeloblastic leukemia (MDS-AML)E M Pogliani, L Baldicchi, P Pioltelli, et al.The International Journal of Biological Markers|January 1, 1990
Immunoreactive calcitonin: a tumor marker for myelogenous leukemiasP Foa, S Ortolani, E M Pogliani, et al.Acta Haematologica|January 1, 1991
The role of haematopoietic growth factors in bone marrow transplantationE E PolliIsrael Journal of Medical Sciences|December 1, 1978
Results of the therapy of acute leukemia. A cooperative trial by the Italian Association Against LeukemiasE E PolliRecenti Progressi in Medicina|April 1, 1990
[Physiology of fibrinolysis and thrombolytic agents]D Perego, E M PoglianiAnnali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|January 1, 1991
[Hematopoietic tissue growth factors: clinical factors]E E Polli, P FoaThrombosis and Haemostasis|December 23, 1981
GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge densityE Cofrancesco, A Vigo, E M PoglianiAnnali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1991
Chronic myelogenous leukemia: state of the artE E Polli, E Pozzoli, C AnnaloroHaematologica|November 1, 1992
Antiphospholipid antibodies and splenic thrombosis in a patient with idiopathic myelofibrosis (antiphospholipid antibodies and thrombosis)E R Bregani, G Corneo, E M PoglianiPageof 13